The mandatory stock EpiPen requirement, while well-intentioned, creates significant practical, financial, medical, and legal challenges for child care providers. These concerns are not about refusing to keep children safe—they're about ensuring that safety measures are effective, sustainable, and appropriate for the providers who must implement them.

Providers need:

• Practical solutions that match their training and expertise

• Financial sustainability

• Legal protection

• Clear guidelines and support

• Partnership with regulators in developing effective policies